Amylyx Pharmaceuticals, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending September 30, 2024: USD 1.04 M

Amylyx Pharmaceuticals, Inc. Depreciation And Amortization is USD 1.04 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 7.84% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Amylyx Pharmaceuticals, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 969.00 K.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased